
    
      The objective of this study is to obtain the information on dosage and administration,
      safety, and efficacy of Revatio when it is administered for a long period of time (1 year)
      under the actual use after the approval of the dosage and administration in pediatric
      patients (aged 1 year or older, weighed 8 kg or more) .
    
  